{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:34:41Z","timestamp":1794332081913,"version":"4.9.0"},"reference-count":278,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI156186"],"award-info":[{"award-number":["AI156186"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM115474"],"award-info":[{"award-number":["GM115474"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>T helper 17 (Th17) cells have been implicated in numerous inflammatory autoimmune diseases. Clinical benefits from targeting Th17 cell-related cytokines, such as IL-17 and IL-23, highlight how knowledge of Th17 cell development and effector function can be translated into treatments for inflammatory disease. Here we discuss the pathogenic roles of Th17 cells in autoimmune diseases such as multiple sclerosis, inflammatory bowel disease and psoriasis, with emphasis on the cytokines, transcriptional regulators and metabolites that influence Th17 cell differentiation and pathogenicity. Moreover, we address how intestinal environments and physiological responses affect Th17 cells in autoimmune diseases. We also examine current and emerging therapeutic strategies aimed at regulating Th17 cell-driven inflammation to mitigate autoimmune diseases.<\/jats:p>","DOI":"10.1038\/s12276-025-01535-9","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:02:14Z","timestamp":1756684934000},"page":"1913-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Th17 cell pathogenicity in autoimmune disease"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-664X","authenticated-orcid":false,"given":"Eunchong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-5260","authenticated-orcid":false,"given":"Maria","family":"Ciofani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"1535_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"1535_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","volume":"4","author":"II Ivanov","year":"2008","unstructured":"Ivanov, I. I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337\u2013349 (2008).","journal-title":"Cell Host Microbe"},{"key":"1535_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"1535_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282\u2013289 (2008).","journal-title":"Nat. Med."},{"key":"1535_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","volume":"30","author":"H Ishigame","year":"2009","unstructured":"Ishigame, H. et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108\u2013119 (2009).","journal-title":"Immunity"},{"key":"1535_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.194.4.519","volume":"194","author":"P Ye","year":"2001","unstructured":"Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519\u2013527 (2001).","journal-title":"J. Exp. Med."},{"key":"1535_CR7","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","volume":"182","author":"Z Jaffar","year":"2009","unstructured":"Jaffar, Z., Ferrini, M. E., Herritt, L. A. & Roberts, K. Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J. Immunol. 182, 4507\u20134511 (2009).","journal-title":"J. Immunol."},{"key":"1535_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee, J. S. et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43, 727\u2013738 (2015).","journal-title":"Immunity"},{"key":"1535_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P. R. et al. Transforming growth factor-\u03b2 induces development of the TH17 lineage. Nature 441, 231\u2013234 (2006).","journal-title":"Nature"},{"key":"1535_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","volume":"14","author":"SJ Aujla","year":"2008","unstructured":"Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 275\u2013281 (2008).","journal-title":"Nat. Med."},{"key":"1535_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","volume":"21","author":"JK Kolls","year":"2010","unstructured":"Kolls, J. K. & Khader, S. A. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21, 443\u2013448 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1535_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41385-020-0327-1","volume":"14","author":"FR Kirchner","year":"2021","unstructured":"Kirchner, F. R. & LeibundGut-Landmann, S. Tissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa. Mucosal Immunol. 14, 455\u2013467 (2021).","journal-title":"Mucosal Immunol."},{"key":"1535_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","volume":"176","author":"P Bacher","year":"2019","unstructured":"Bacher, P. et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176, 1340\u20131355 e1315 (2019).","journal-title":"Cell"},{"key":"1535_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133\u20131141 (2005).","journal-title":"Nat. Immunol."},{"key":"1535_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744\u2013748 (2003).","journal-title":"Nature"},{"key":"1535_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med"},{"key":"1535_CR17","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","volume":"180","author":"X Liu","year":"2008","unstructured":"Liu, X., Lee, Y. S., Yu, C. R. & Egwuagu, C. E. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180, 6070\u20136076 (2008).","journal-title":"J. Immunol."},{"key":"1535_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2008.08.030","volume":"130","author":"M Montes","year":"2009","unstructured":"Montes, M. et al. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin. Immunol. 130, 133\u2013144 (2009).","journal-title":"Clin. Immunol."},{"key":"1535_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm0502-500","volume":"8","author":"C Lock","year":"2002","unstructured":"Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500\u2013508 (2002).","journal-title":"Nat. Med."},{"key":"1535_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J. S. et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"1535_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.21652","volume":"65","author":"L Durelli","year":"2009","unstructured":"Durelli, L. et al. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-\u03b2. Ann. Neurol. 65, 499\u2013509 (2009).","journal-title":"Ann. Neurol."},{"key":"1535_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ana.21748","volume":"66","author":"H Kebir","year":"2009","unstructured":"Kebir, H. et al. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66, 390\u2013402 (2009).","journal-title":"Ann. Neurol."},{"key":"1535_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/08916934.2016.1138271","volume":"49","author":"A Teniente-Serra","year":"2016","unstructured":"Teniente-Serra, A. et al. Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients. Autoimmunity 49, 219\u2013228 (2016).","journal-title":"Autoimmunity"},{"key":"1535_CR24","first-page":"205521731989969","volume":"6","author":"S Kalra","year":"2020","unstructured":"Kalra, S. et al. Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only. Mult. Scler. J. Exp. Transl. Clin. 6, 2055217319899695 (2020).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"1535_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/135245859900500206","volume":"5","author":"D Matusevicius","year":"1999","unstructured":"Matusevicius, D. et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5, 101\u2013104 (1999).","journal-title":"Mult. Scler."},{"key":"1535_CR26","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awp289","volume":"132","author":"V Brucklacher-Waldert","year":"2009","unstructured":"Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J. & Tolosa, E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329\u20133341 (2009).","journal-title":"Brain"},{"key":"1535_CR27","doi-asserted-by":"publisher","first-page":"817473","DOI":"10.3389\/fimmu.2022.817473","volume":"13","author":"AHS Heng","year":"2022","unstructured":"Heng, A. H. S., Han, C. W., Abbott, C., McColl, S. R. & Comerford, I. Chemokine-driven migration of pro-inflammatory CD4+ T cells in CNS autoimmune disease. Front Immunol. 13, 817473 (2022).","journal-title":"Front Immunol."},{"key":"1535_CR28","doi-asserted-by":"publisher","first-page":"eabj0473","DOI":"10.1126\/scitranslmed.abj0473","volume":"14","author":"M Charabati","year":"2022","unstructured":"Charabati, M. et al. DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation. Sci. Transl. Med 14, eabj0473 (2022).","journal-title":"Sci. Transl. Med"},{"key":"1535_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.celrep.2016.06.065","volume":"16","author":"F Du","year":"2016","unstructured":"Du, F. et al. Inflammatory Th17 cells express integrin \u03b1v\u03b23 for pathogenic function. Cell Rep. 16, 1339\u20131351 (2016).","journal-title":"Cell Rep."},{"key":"1535_CR30","doi-asserted-by":"publisher","first-page":"eadg7597","DOI":"10.1126\/sciimmunol.adg7597","volume":"8","author":"E Park","year":"2023","unstructured":"Park, E. et al. Integrin \u03b13 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation. Sci. Immunol. 8, eadg7597 (2023).","journal-title":"Sci. Immunol."},{"key":"1535_CR31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir, H. et al. Human TH17 lymphocytes promote blood\u2013brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173\u20131175 (2007).","journal-title":"Nat. Med."},{"key":"1535_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1096\/fj.09-141978","volume":"24","author":"J Huppert","year":"2010","unstructured":"Huppert, J. et al. Cellular mechanisms of IL-17-induced blood\u2013brain barrier disruption. FASEB J. 24, 1023\u20131034 (2010).","journal-title":"FASEB J."},{"key":"1535_CR33","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593\u20132603 (1996).","journal-title":"J. Exp. Med."},{"key":"1535_CR34","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-\u03b2 and TNF-\u03b1, by human macrophages. J. Immunol. 160, 3513\u20133521 (1998).","journal-title":"J. Immunol."},{"key":"1535_CR35","doi-asserted-by":"publisher","unstructured":"Lin, W. et al. RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201744951 (2018).","DOI":"10.15252\/embr.201744951"},{"key":"1535_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/glia.22307","volume":"60","author":"GP Meares","year":"2012","unstructured":"Meares, G. P., Ma, X., Qin, H. & Benveniste, E. N. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60, 771\u2013781 (2012).","journal-title":"Glia"},{"key":"1535_CR37","doi-asserted-by":"publisher","first-page":"678744","DOI":"10.3389\/fimmu.2021.678744","volume":"12","author":"YM Qiu","year":"2021","unstructured":"Qiu, Y. M. et al. Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?. Front. Immunol. 12, 678744 (2021).","journal-title":"Front. Immunol."},{"key":"1535_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1471-4159.2010.07136.x","volume":"116","author":"MK Paintlia","year":"2011","unstructured":"Paintlia, M. K., Paintlia, A. S., Singh, A. K. & Singh, I. Synergistic activity of interleukin-17 and tumor necrosis factor-alpha enhances oxidative stress-mediated oligodendrocyte apoptosis. J. Neurochem. 116, 508\u2013521 (2011).","journal-title":"J. Neurochem."},{"key":"1535_CR39","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.4049\/jimmunol.179.12.8098","volume":"179","author":"K Kreymborg","year":"2007","unstructured":"Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098\u20138104 (2007).","journal-title":"J. Immunol."},{"key":"1535_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molimm.2016.12.020","volume":"82","author":"J Zhen","year":"2017","unstructured":"Zhen, J. et al. IL-22 promotes Fas expression in oligodendrocytes and inhibits FOXP3 expression in T cells by activating the NF-\u03baB pathway in multiple sclerosis. Mol. Immunol. 82, 84\u201393 (2017).","journal-title":"Mol. Immunol."},{"key":"1535_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.178.1.39","volume":"178","author":"ED Ponomarev","year":"2007","unstructured":"Ponomarev, E. D. et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39\u201348 (2007).","journal-title":"J. Immunol."},{"key":"1535_CR42","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri, L. et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560\u2013567 (2011).","journal-title":"Nat. Immunol."},{"key":"1535_CR43","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","volume":"50","author":"J Komuczki","year":"2019","unstructured":"Komuczki, J. et al. Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1\u03b2. Immunity 50, 1289\u20131304 (2019).","journal-title":"Immunity"},{"key":"1535_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/08923979809034820","volume":"20","author":"PB Carrieri","year":"1998","unstructured":"Carrieri, P. B. et al. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20, 373\u2013382 (1998).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"1535_CR45","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.4049\/jimmunol.1403243","volume":"194","author":"J Rasouli","year":"2015","unstructured":"Rasouli, J. et al. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-\u03b2 therapy. J. Immunol. 194, 5085\u20135093 (2015).","journal-title":"J. Immunol."},{"key":"1535_CR46","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/cr.2014.154","volume":"24","author":"W Sheng","year":"2014","unstructured":"Sheng, W. et al. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation. Cell Res. 24, 1387\u20131402 (2014).","journal-title":"Cell Res."},{"key":"1535_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.1993","volume":"12","author":"K Hirota","year":"2011","unstructured":"Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255\u2013263 (2011).","journal-title":"Nat. Immunol."},{"key":"1535_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ni.2031","volume":"12","author":"M El-Behi","year":"2011","unstructured":"El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568\u2013575 (2011).","journal-title":"Nat. Immunol."},{"key":"1535_CR49","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","volume":"113","author":"IL King","year":"2009","unstructured":"King, I. L., Dickendesher, T. L. & Segal, B. M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190\u20133197 (2009).","journal-title":"Blood"},{"key":"1535_CR50","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.4049\/jimmunol.1600737","volume":"198","author":"SA Basdeo","year":"2017","unstructured":"Basdeo, S. A. et al. Ex-Th17 (nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells. J. Immunol. 198, 2249\u20132259 (2017).","journal-title":"J. Immunol."},{"key":"1535_CR51","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1073\/pnas.1415675112","volume":"112","author":"SN Harbour","year":"2015","unstructured":"Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. Natl Acad. Sci. USA 112, 7061\u20137066 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR52","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.1073\/pnas.1003852107","volume":"107","author":"K Nistala","year":"2010","unstructured":"Nistala, K. et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl Acad. Sci. USA 107, 14751\u201314756 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR53","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1002\/eji.201343723","volume":"43","author":"HM Grifka-Walk","year":"2013","unstructured":"Grifka-Walk, H. M., Lalor, S. J. & Segal, B. M. Highly polarized Th17 cells induce EAE via a T-bet independent mechanism. Eur. J. Immunol. 43, 2824\u20132831 (2013).","journal-title":"Eur. J. Immunol."},{"key":"1535_CR54","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","volume":"184","author":"A Schnell","year":"2021","unstructured":"Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281\u20136298 (2021).","journal-title":"Cell"},{"key":"1535_CR55","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","volume":"35","author":"P Muranski","year":"2011","unstructured":"Muranski, P. et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35, 972\u2013985 (2011).","journal-title":"Immunity"},{"key":"1535_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-018-0806-7","volume":"565","author":"PWF Karmaus","year":"2019","unstructured":"Karmaus, P. W. F. et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature 565, 101\u2013105 (2019).","journal-title":"Nature"},{"key":"1535_CR57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin, V. et al. In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424\u2013436 (2010).","journal-title":"Immunity"},{"key":"1535_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65\u201370 (2003).","journal-title":"Gut"},{"key":"1535_CR59","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00011-014-0768-7","volume":"63","author":"W Jiang","year":"2014","unstructured":"Jiang, W. et al. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm. Res. 63, 943\u2013950 (2014).","journal-title":"Inflamm. Res."},{"key":"1535_CR60","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ibd.20339","volume":"14","author":"J Seiderer","year":"2008","unstructured":"Seiderer, J. et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn\u2019s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm. Bowel Dis. 14, 437\u2013445 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"1535_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1084\/jem.20081712","volume":"206","author":"MA Kleinschek","year":"2009","unstructured":"Kleinschek, M. A. et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med 206, 525\u2013534 (2009).","journal-title":"J. Exp. Med"},{"key":"1535_CR62","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693\u20131700 (2012).","journal-title":"Gut"},{"key":"1535_CR63","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/ajg.2016.298","volume":"111","author":"SR Targan","year":"2016","unstructured":"Targan, S. R. et al. A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn\u2019s disease. Am. J. Gastroenterol. 111, 1599\u20131607 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"1535_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"O\u2019Connor","year":"2009","unstructured":"O\u2019Connor et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603\u2013609 (2009).","journal-title":"Nat. Immunol."},{"key":"1535_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","volume":"110","author":"A Ogawa","year":"2004","unstructured":"Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55\u201362 (2004).","journal-title":"Clin. Immunol."},{"key":"1535_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","volume":"136","author":"M Leppkes","year":"2009","unstructured":"Leppkes, M. et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257\u2013267 (2009).","journal-title":"Gastroenterology"},{"key":"1535_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","volume":"33","author":"PP Ahern","year":"2010","unstructured":"Ahern, P. P. et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279\u2013288 (2010).","journal-title":"Immunity"},{"key":"1535_CR68","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310\u20131316 (2006).","journal-title":"J. Clin. Invest."},{"key":"1535_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","volume":"25","author":"HH Uhlig","year":"2006","unstructured":"Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309\u2013318 (2006).","journal-title":"Immunity"},{"key":"1535_CR70","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","volume":"30","author":"YK Lee","year":"2009","unstructured":"Lee, Y. K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92\u2013107 (2009).","journal-title":"Immunity"},{"key":"1535_CR71","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461\u20131463 (2006).","journal-title":"Science"},{"key":"1535_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-1536-6-13","volume":"6","author":"P Biancheri","year":"2013","unstructured":"Biancheri, P. et al. The role of interleukin 17 in Crohn\u2019s disease-associated intestinal fibrosis. Fibrogenesis Tissue Repair 6, 13 (2013).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1535_CR73","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1007\/s10620-018-5234-x","volume":"63","author":"HJ Zhang","year":"2018","unstructured":"Zhang, H. J. et al. IL-17A promotes initiation and development of intestinal fibrosis through EMT. Dig. Dis. Sci. 63, 2898\u20132909 (2018).","journal-title":"Dig. Dis. Sci."},{"key":"1535_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/j.gastro.2022.09.006","volume":"164","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Th17 cell-derived amphiregulin promotes colitis-associated intestinal fibrosis through activation of mTOR and MEK in intestinal myofibroblasts. Gastroenterology 164, 89\u2013102 (2023).","journal-title":"Gastroenterology"},{"key":"1535_CR75","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","volume":"111","author":"MB Teunissen","year":"1998","unstructured":"Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A. & Bos, J. D. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111, 645\u2013649 (1998).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR76","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950\u2013957 (2007).","journal-title":"Nat. Immunol."},{"key":"1535_CR77","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes, M. A. et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207\u20131211 (2008).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR78","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1203475415584503","volume":"19","author":"C Fotiadou","year":"2015","unstructured":"Fotiadou, C. et al. IL-17A, IL-22, and IL-23 as markers of psoriasis activity: a cross-sectional, hospital-based study. J. Cutan. Med. Surg. 19, 555\u2013560 (2015).","journal-title":"J. Cutan. Med. Surg."},{"key":"1535_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2015.06.011","volume":"80","author":"A Batalla","year":"2015","unstructured":"Batalla, A. et al. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and psoriasis in a Spanish cohort. J. Dermatol. Sci. 80, 111\u2013115 (2015).","journal-title":"J. Dermatol. Sci."},{"key":"1535_CR80","doi-asserted-by":"publisher","first-page":"eadi2848","DOI":"10.1126\/sciimmunol.adi2848","volume":"9","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Sci. Immunol. 9, eadi2848 (2024).","journal-title":"Sci. Immunol."},{"key":"1535_CR81","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","volume":"184","author":"K Guilloteau","year":"2010","unstructured":"Guilloteau, K. et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1\u03b1, and TNF-\u03b1 recapitulates some features of psoriasis. J. Immunol. 184, 5263\u20135270 (2010).","journal-title":"J. Immunol."},{"key":"1535_CR82","doi-asserted-by":"publisher","unstructured":"Batta, S. et al. IL-17 and -23 inhibitors for the treatment of psoriasis. EMJ Allergy Immunol. https:\/\/doi.org\/10.33590\/emjallergyimmunol\/10301362 (2023).","DOI":"10.33590\/emjallergyimmunol\/10301362"},{"key":"1535_CR83","first-page":"597","volume":"118","author":"HL Ma","year":"2008","unstructured":"Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118, 597\u2013607 (2008).","journal-title":"J. Clin. Invest."},{"key":"1535_CR84","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651 (2007).","journal-title":"Nature"},{"key":"1535_CR85","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/jid.2014.5","volume":"134","author":"P Nikamo","year":"2014","unstructured":"Nikamo, P. et al. Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells. J. Invest. Dermatol. 134, 1535\u20131541 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00005-018-0527-5","volume":"67","author":"B Wawrzycki","year":"2019","unstructured":"Wawrzycki, B. et al. Interleukin-22 and its correlation with disease activity in plaque psoriasis. Arch. Immunol. Ther. Exp. 67, 103\u2013108 (2019).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"1535_CR87","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles, K. E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol 159, 1092\u20131102 (2008).","journal-title":"Br. J. Dermatol"},{"key":"1535_CR88","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","volume":"87","author":"K Wolk","year":"2009","unstructured":"Wolk, K. et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-\u03b3 are not. J. Mol. Med (Berl.) 87, 523\u2013536 (2009).","journal-title":"J. Mol. Med (Berl.)"},{"key":"1535_CR89","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle, A. B. et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 188, 462\u2013469 (2012).","journal-title":"J. Immunol."},{"key":"1535_CR90","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","volume":"130","author":"S Kagami","year":"2010","unstructured":"Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y. & Blauvelt, A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 130, 1373\u20131383 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR91","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","volume":"181","author":"I Kryczek","year":"2008","unstructured":"Kryczek, I. et al. Induction of IL-17+ T cell trafficking and development by IFN-\u03b3: mechanism and pathological relevance in psoriasis. J. Immunol. 181, 4733\u20134741 (2008).","journal-title":"J. Immunol."},{"key":"1535_CR92","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1073\/pnas.0810769106","volume":"106","author":"G Iezzi","year":"2009","unstructured":"Iezzi, G. et al. CD40\u2013CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc. Natl Acad. Sci. USA 106, 876\u2013881 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR93","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1084\/jem.20131459","volume":"211","author":"J Gomez-Rodriguez","year":"2014","unstructured":"Gomez-Rodriguez, J. et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J. Exp. Med. 211, 529\u2013543 (2014).","journal-title":"J. Exp. Med."},{"key":"1535_CR94","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.4049\/jimmunol.1501016","volume":"195","author":"I Kastirr","year":"2015","unstructured":"Kastirr, I. et al. Signal strength and metabolic requirements control cytokine-induced Th17 differentiation of uncommitted human T cells. J. Immunol. 195, 3617\u20133627 (2015).","journal-title":"J. Immunol."},{"key":"1535_CR95","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.celrep.2018.02.044","volume":"22","author":"S Revu","year":"2018","unstructured":"Revu, S. et al. IL-23 and IL-1\u03b2 drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation. Cell Rep. 22, 2642\u20132653 (2018).","journal-title":"Cell Rep."},{"key":"1535_CR96","doi-asserted-by":"publisher","first-page":"55ra78","DOI":"10.1126\/scitranslmed.3000448","volume":"2","author":"CM Paulos","year":"2010","unstructured":"Paulos, C. M. et al. The inducible costimulator (ICOS) is critical for the development of human TH17 cells. Sci. Transl. Med. 2, 55ra78 (2010).","journal-title":"Sci. Transl. Med."},{"key":"1535_CR97","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1182\/blood-2010-03-272153","volume":"116","author":"HA Purvis","year":"2010","unstructured":"Purvis, H. A. et al. Low-strength T-cell activation promotes Th17 responses. Blood 116, 4829\u20134837 (2010).","journal-title":"Blood"},{"key":"1535_CR98","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"1535_CR99","doi-asserted-by":"publisher","first-page":"eadc9662","DOI":"10.1126\/scisignal.adc9662","volume":"17","author":"F Baumgartner","year":"2024","unstructured":"Baumgartner, F. et al. Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity. Sci. Signal 17, eadc9662 (2024).","journal-title":"Sci. Signal"},{"key":"1535_CR100","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","volume":"105","author":"T Korn","year":"2008","unstructured":"Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 105, 18460\u201318465 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR101","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480\u2013483 (2007).","journal-title":"Nature"},{"key":"1535_CR102","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484\u2013487 (2007).","journal-title":"Nature"},{"key":"1535_CR103","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967\u2013974 (2007).","journal-title":"Nat. Immunol."},{"key":"1535_CR104","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1074\/jbc.M705100200","volume":"282","author":"L Wei","year":"2007","unstructured":"Wei, L., Laurence, A., Elias, K. M. & O\u2019Shea, J. J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282, 34605\u201334610 (2007).","journal-title":"J. Biol. Chem."},{"key":"1535_CR105","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3. J. Exp. Med. 198, 1875\u20131886 (2003).","journal-title":"J. Exp. Med."},{"key":"1535_CR106","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling. Nature 467, 967\u2013971 (2010).","journal-title":"Nature"},{"key":"1535_CR107","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20082286","volume":"206","author":"J Das","year":"2009","unstructured":"Das, J. et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206, 2407\u20132416 (2009).","journal-title":"J. Exp. Med."},{"key":"1535_CR108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.12938","volume":"155","author":"S Zhang","year":"2018","unstructured":"Zhang, S. The role of transforming growth factor beta in T helper 17 differentiation. Immunology 155, 24\u201335 (2018).","journal-title":"Immunology"},{"key":"1535_CR109","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"1535_CR110","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1\u03b2 and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942\u2013949 (2007).","journal-title":"Nat. Immunol."},{"key":"1535_CR111","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/eji.200838748","volume":"39","author":"V Santarlasci","year":"2009","unstructured":"Santarlasci, V. et al. TGF-\u03b2 indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 39, 207\u2013215 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1535_CR112","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy, M. J. et al. TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8, 1390\u20131397 (2007).","journal-title":"Nat. Immunol."},{"key":"1535_CR113","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20060285","volume":"203","author":"C Sutton","year":"2006","unstructured":"Sutton, C., Brereton, C., Keogh, B., Mills, K. H. & Lavelle, E. C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685\u20131691 (2006).","journal-title":"J. Exp. Med."},{"key":"1535_CR114","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576\u2013587 (2009).","journal-title":"Immunity"},{"key":"1535_CR115","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4049\/jimmunol.1300387","volume":"192","author":"S Ikeda","year":"2014","unstructured":"Ikeda, S. et al. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-\u03b2-induced Foxp3 expression. J. Immunol. 192, 1449\u20131458 (2014).","journal-title":"J. Immunol."},{"key":"1535_CR116","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15252\/embj.201694615","volume":"36","author":"IA Mufazalov","year":"2017","unstructured":"Mufazalov, I. A. et al. IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells. EMBO J. 36, 102\u2013115 (2017).","journal-title":"EMBO J."},{"key":"1535_CR117","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","volume":"151","author":"M Ciofani","year":"2012","unstructured":"Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289\u2013303 (2012).","journal-title":"Cell"},{"key":"1535_CR118","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","volume":"178","author":"AN Mathur","year":"2007","unstructured":"Mathur, A. N. et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178, 4901\u20134907 (2007).","journal-title":"J. Immunol."},{"key":"1535_CR119","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358\u20139363 (2007).","journal-title":"J. Biol. Chem."},{"key":"1535_CR120","doi-asserted-by":"publisher","first-page":"108316","DOI":"10.1016\/j.clim.2019.108316","volume":"210","author":"S Jagle","year":"2020","unstructured":"Jagle, S. et al. Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity. Clin. Immunol. 210, 108316 (2020).","journal-title":"Clin. Immunol."},{"key":"1535_CR121","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner, J. D. et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125, 591\u2013599 (2015).","journal-title":"Blood"},{"key":"1535_CR122","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"SE Flanagan","year":"2014","unstructured":"Flanagan, S. E. et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat. Genet. 46, 812\u2013814 (2014).","journal-title":"Nat. Genet."},{"key":"1535_CR123","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1073\/pnas.0705268104","volume":"104","author":"A Kimura","year":"2007","unstructured":"Kimura, A., Naka, T. & Kishimoto, T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl Acad. Sci. USA 104, 12099\u201312104 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR124","first-page":"626","volume":"5","author":"Z Gao","year":"2012","unstructured":"Gao, Z. et al. Synergy between IL-6 and TGF-\u03b2 signaling promotes FOXP3 degradation. Int J. Clin. Exp. Pathol. 5, 626\u2013633 (2012).","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"1535_CR125","doi-asserted-by":"publisher","first-page":"29044","DOI":"10.1074\/jbc.C110.156745","volume":"285","author":"N Malhotra","year":"2010","unstructured":"Malhotra, N., Robertson, E. & Kang, J. SMAD2 is essential for TGF \u03b2-mediated Th17 cell generation. J. Biol. Chem. 285, 29044\u201329048 (2010).","journal-title":"J. Biol. Chem."},{"key":"1535_CR126","doi-asserted-by":"publisher","first-page":"29039","DOI":"10.1074\/jbc.C110.155820","volume":"285","author":"GJ Martinez","year":"2010","unstructured":"Martinez, G. J. et al. Smad2 positively regulates the generation of Th17 cells. J. Biol. Chem. 285, 29039\u201329043 (2010).","journal-title":"J. Biol. Chem."},{"key":"1535_CR127","doi-asserted-by":"publisher","first-page":"35283","DOI":"10.1074\/jbc.C109.078238","volume":"284","author":"GJ Martinez","year":"2009","unstructured":"Martinez, G. J. et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J. Biol. Chem. 284, 35283\u201335286 (2009).","journal-title":"J. Biol. Chem."},{"key":"1535_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8600","volume":"6","author":"JH Yoon","year":"2015","unstructured":"Yoon, J. H. et al. Phosphorylation status determines the opposing functions of Smad2\/Smad3 as STAT3 cofactors in TH17 differentiation. Nat. Commun. 6, 7600 (2015).","journal-title":"Nat. Commun."},{"key":"1535_CR129","doi-asserted-by":"publisher","first-page":"842","DOI":"10.4049\/jimmunol.0904100","volume":"185","author":"T Takimoto","year":"2010","unstructured":"Takimoto, T. et al. Smad2 and Smad3 are redundantly essential for the TGF-\u03b2-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 185, 842\u2013855 (2010).","journal-title":"J. Immunol."},{"key":"1535_CR130","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.4049\/jimmunol.0903418","volume":"184","author":"L Lu","year":"2010","unstructured":"Lu, L. et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J. Immunol. 184, 4295\u20134306 (2010).","journal-title":"J. Immunol."},{"key":"1535_CR131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature24283","volume":"551","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551, 105\u2013109 (2017).","journal-title":"Nature"},{"key":"1535_CR132","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1172\/JCI45114","volume":"121","author":"JN Hahn","year":"2011","unstructured":"Hahn, J. N., Falck, V. G. & Jirik, F. R. Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice. J. Clin. Invest. 121, 4030\u20134042 (2011).","journal-title":"J. Clin. Invest."},{"key":"1535_CR133","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44\u201356 (2008).","journal-title":"Immunity"},{"key":"1535_CR134","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1084\/jem.20012076","volume":"195","author":"L Gorelik","year":"2002","unstructured":"Gorelik, L., Constant, S. & Flavell, R. A. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195, 1499\u20131505 (2002).","journal-title":"J. Exp. Med."},{"key":"1535_CR135","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7","volume":"6","author":"VL Heath","year":"2000","unstructured":"Heath, V. L. et al. TGF-\u03b21 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 6, 2639\u20132649 (2000).","journal-title":"Eur. J. Immunol."},{"key":"1535_CR136","doi-asserted-by":"publisher","first-page":"8700","DOI":"10.4049\/jimmunol.181.12.8700","volume":"181","author":"Y Yang","year":"2008","unstructured":"Yang, Y., Xu, J., Niu, Y., Bromberg, J. S. & Ding, Y. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J. Immunol. 181, 8700\u20138710 (2008).","journal-title":"J. Immunol."},{"key":"1535_CR137","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ni931","volume":"4","author":"BA Croker","year":"2003","unstructured":"Croker, B. A. et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540\u2013545 (2003).","journal-title":"Nat. Immunol."},{"key":"1535_CR138","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137\u20138142 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR139","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.0801986","volume":"183","author":"H Qin","year":"2009","unstructured":"Qin, H. et al. TGF-\u03b2 promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 183, 97\u2013105 (2009).","journal-title":"J. Immunol."},{"key":"1535_CR140","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.immuni.2011.02.021","volume":"34","author":"K Ichiyama","year":"2011","unstructured":"Ichiyama, K. et al. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin. Immunity 34, 741\u2013754 (2011).","journal-title":"Immunity"},{"key":"1535_CR141","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1084\/jem.20081666","volume":"206","author":"J Zhu","year":"2009","unstructured":"Zhu, J. et al. Down-regulation of Gfi-1 expression by TGF-\u03b2 is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J. Exp. Med 206, 329\u2013341 (2009).","journal-title":"J. Exp. Med"},{"key":"1535_CR142","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.celrep.2019.09.064","volume":"29","author":"D Pham","year":"2019","unstructured":"Pham, D. et al. Batf pioneers the reorganization of chromatin in developing effector T cells via Ets1-dependent recruitment of Ctcf. Cell Rep. 29, 1203\u20131220 e1207 (2019).","journal-title":"Cell Rep."},{"key":"1535_CR143","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature08114","volume":"460","author":"BU Schraml","year":"2009","unstructured":"Schraml, B. U. et al. The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460, 405\u2013409 (2009). doi:nature08114 [pii].","journal-title":"Nature"},{"key":"1535_CR144","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni1500","volume":"8","author":"A Brustle","year":"2007","unstructured":"Brustle, A. et al. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958\u2013966 (2007).","journal-title":"Nat. Immunol."},{"key":"1535_CR145","doi-asserted-by":"publisher","first-page":"20846","DOI":"10.1073\/pnas.0809077106","volume":"105","author":"M Huber","year":"2008","unstructured":"Huber, M. et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl Acad. Sci. USA 105, 20846\u201320851 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR146","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ni.1690","volume":"10","author":"AT Bauquet","year":"2009","unstructured":"Bauquet, A. T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167\u2013175 (2009).","journal-title":"Nat. Immunol."},{"key":"1535_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00380-3","volume":"8","author":"TM Carr","year":"2017","unstructured":"Carr, T. M., Wheaton, J. D., Houtz, G. M. & Ciofani, M. JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation. Nat. Commun. 8, 301 (2017).","journal-title":"Nat. Commun."},{"key":"1535_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15628","volume":"8","author":"Z Hasan","year":"2017","unstructured":"Hasan, Z. et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat. Commun. 8, 15628 (2017).","journal-title":"Nat. Commun."},{"key":"1535_CR149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29\u201339 (2008).","journal-title":"Immunity"},{"key":"1535_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20385-9","volume":"12","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Genetic and pharmacological inhibition of the nuclear receptor ROR\u03b1 regulates TH17 driven inflammatory disorders. Nat. Commun. 12, 76 (2021).","journal-title":"Nat. Commun."},{"key":"1535_CR151","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.immuni.2022.09.013","volume":"55","author":"JA Hall","year":"2022","unstructured":"Hall, J. A. et al. Transcription factor ROR\u03b1 enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element. Immunity 55, 2027\u20132043 (2022).","journal-title":"Immunity"},{"key":"1535_CR152","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nature08922","volume":"464","author":"K Okamoto","year":"2010","unstructured":"Okamoto, K. et al. I\u03baB\u03be regulates TH17 development by cooperating with ROR nuclear receptors. Nature 464, 1381\u20131385 (2010).","journal-title":"Nature"},{"key":"1535_CR153","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ni.1663","volume":"9","author":"F Zhang","year":"2008","unstructured":"Zhang, F., Meng, G. & Strober, W. Interactions among the transcription factors Runx1, ROR\u03b3t and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297\u20131306 (2008).","journal-title":"Nat. Immunol."},{"key":"1535_CR154","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","volume":"44","author":"R Jain","year":"2016","unstructured":"Jain, R. et al. Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44, 131\u2013142 (2016).","journal-title":"Immunity"},{"key":"1535_CR155","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.immuni.2024.09.017","volume":"57","author":"D Mangani","year":"2024","unstructured":"Mangani, D. et al. Transcription factor TCF1 binds to ROR\u03b3t and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity 57, 2565\u20132582 (2024).","journal-title":"Immunity"},{"key":"1535_CR156","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41590-024-01901-1","volume":"25","author":"PI Thakore","year":"2024","unstructured":"Thakore, P. I. et al. BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells. Nat. Immunol. 25, 1395\u20131410 (2024).","journal-title":"Nat. Immunol."},{"key":"1535_CR157","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","volume":"40","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells. Immunity 40, 355\u2013366 (2014).","journal-title":"Immunity"},{"key":"1535_CR158","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E. V. et al. Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"1535_CR159","doi-asserted-by":"publisher","first-page":"e2312111121","DOI":"10.1073\/pnas.2312111121","volume":"121","author":"KL Cheung","year":"2024","unstructured":"Cheung, K. L. et al. Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation. Proc. Natl Acad. Sci. USA 121, e2312111121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR160","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1074\/jbc.C600322200","volume":"282","author":"AM Akimzhanov","year":"2007","unstructured":"Akimzhanov, A. M., Yang, X. O. & Dong, C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J. Biol. Chem. 282, 5969\u20135972 (2007).","journal-title":"J. Biol. Chem."},{"key":"1535_CR161","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","volume":"30","author":"G Wei","year":"2009","unstructured":"Wei, G. et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155\u2013167 (2009).","journal-title":"Immunity"},{"key":"1535_CR162","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jmcb\/mjv022","volume":"7","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. J. Mol. Cell Biol. 7, 505\u2013516 (2015).","journal-title":"J. Mol. Cell Biol."},{"key":"1535_CR163","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.immuni.2010.04.016","volume":"32","author":"R Mukasa","year":"2010","unstructured":"Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616\u2013627 (2010).","journal-title":"Immunity"},{"key":"1535_CR164","doi-asserted-by":"publisher","first-page":"25049","DOI":"10.1074\/jbc.M112.351916","volume":"287","author":"RM Thomas","year":"2012","unstructured":"Thomas, R. M., Sai, H. & Wells, A. D. Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus. J. Biol. Chem. 287, 25049\u201325059 (2012).","journal-title":"J. Biol. Chem."},{"key":"1535_CR165","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.immuni.2020.07.012","volume":"53","author":"D Chang","year":"2020","unstructured":"Chang, D. et al. The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced rorc transcription during T helper 17 cell differentiation. Immunity 53, 614\u2013626 e614 (2020).","journal-title":"Immunity"},{"key":"1535_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20786-w","volume":"12","author":"Y Tian","year":"2021","unstructured":"Tian, Y. et al. SOX-5 activates a novel ROR\u03b3t enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation. Nat. Commun. 12, 481 (2021).","journal-title":"Nat. Commun."},{"key":"1535_CR167","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.immuni.2011.10.019","volume":"36","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity 36, 23\u201331 (2012).","journal-title":"Immunity"},{"key":"1535_CR168","doi-asserted-by":"publisher","first-page":"848985","DOI":"10.3389\/fgene.2022.848985","volume":"13","author":"F Tang","year":"2022","unstructured":"Tang, F. et al. MicroRNAs in the regulation of Th17\/Treg homeostasis and their potential role in uveitis. Front. Genet. 13, 848985 (2022).","journal-title":"Front. Genet."},{"key":"1535_CR169","doi-asserted-by":"publisher","first-page":"593473","DOI":"10.3389\/fimmu.2021.593473","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang, J., Xu, X. & Yang, J. miRNAs alter T helper 17 cell fate in the pathogenesis of autoimmune diseases. Front. Immunol. 12, 593473 (2021).","journal-title":"Front. Immunol."},{"key":"1535_CR170","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.immuni.2016.05.015","volume":"44","author":"K Ichiyama","year":"2016","unstructured":"Ichiyama, K. et al. The microRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 Expression. Immunity 44, 1284\u20131298 (2016).","journal-title":"Immunity"},{"key":"1535_CR171","doi-asserted-by":"publisher","first-page":"13951","DOI":"10.1096\/fj.201901446R","volume":"33","author":"Y Wei","year":"2019","unstructured":"Wei, Y. et al. miR-223-3p promotes autoreactive Th17 cell responses in experimental autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression. FASEB J. 33, 13951\u201313965 (2019).","journal-title":"FASEB J."},{"key":"1535_CR172","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbi.2018.03.011","volume":"70","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis. Brain Behav. Immun. 70, 305\u2013314 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1535_CR173","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI74347","volume":"125","author":"G Murugaiyan","year":"2015","unstructured":"Murugaiyan, G. et al. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J. Clin. Invest 125, 1069\u20131080 (2015).","journal-title":"J. Clin. Invest"},{"key":"1535_CR174","doi-asserted-by":"publisher","first-page":"E1248","DOI":"10.1073\/pnas.1114325109","volume":"109","author":"MP Mycko","year":"2012","unstructured":"Mycko, M. P. et al. MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc. Natl Acad. Sci. USA 109, E1248\u2013E1257 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR175","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fncel.2017.00088","volume":"11","author":"X Qu","year":"2017","unstructured":"Qu, X. et al. MiR-384 regulates the Th17\/Treg ratio during experimental autoimmune encephalomyelitis pathogenesis. Front. Cell Neurosci. 11, 88 (2017).","journal-title":"Front. Cell Neurosci."},{"key":"1535_CR176","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/ni.1798","volume":"10","author":"C Du","year":"2009","unstructured":"Du, C. et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 10, 1252\u20131259 (2009).","journal-title":"Nat. Immunol."},{"key":"1535_CR177","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer. Cancer Immunol. Res. 6, 1578\u20131592 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"1535_CR178","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4049\/jimmunol.1700170","volume":"199","author":"MM Montoya","year":"2017","unstructured":"Montoya, M. M. et al. A distinct inhibitory function for miR-18a in Th17 cell differentiation. J. Immunol. 199, 559\u2013569 (2017).","journal-title":"J. Immunol."},{"key":"1535_CR179","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3389\/fimmu.2019.03125","volume":"10","author":"CC Angelou","year":"2019","unstructured":"Angelou, C. C. et al. Differentiation of pathogenic Th17 cells is negatively regulated by Let-7 microRNAs in a mouse model of multiple sclerosis. Front. Immunol. 10, 3125 (2019).","journal-title":"Front. Immunol."},{"key":"1535_CR180","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1172\/JCI94012","volume":"127","author":"B Li","year":"2017","unstructured":"Li, B. et al. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity. J. Clin. Invest 127, 3702\u20133716 (2017).","journal-title":"J. Clin. Invest"},{"key":"1535_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06132-0","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. LncRNA Neat1 targets NonO and miR-128-3p to promote antigen-specific Th17 cell responses and autoimmune inflammation. Cell Death Dis. 14, 610 (2023).","journal-title":"Cell Death Dis."},{"key":"1535_CR182","doi-asserted-by":"publisher","first-page":"6401978","DOI":"10.1155\/2020\/6401978","volume":"2020","author":"H Peng","year":"2020","unstructured":"Peng, H. et al. Elevated expression of the long noncoding RNA IFNG-AS1 in the peripheral blood from patients with rheumatoid arthritis. J. Immunol. Res. 2020, 6401978 (2020).","journal-title":"J. Immunol. Res."},{"key":"1535_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/srep17702","volume":"5","author":"H Peng","year":"2015","unstructured":"Peng, H. et al. The long noncoding RNA IFNG-AS1 promotes T helper type 1 cells response in patients with Hashimoto\u2019s thyroiditis. Sci. Rep. 5, 17702 (2015).","journal-title":"Sci. Rep."},{"key":"1535_CR184","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.molcel.2019.06.025","volume":"75","author":"F Petermann","year":"2019","unstructured":"Petermann, F. et al. The magnitude of IFN-\u03b3 responses is fine-tuned by DNA architecture and the non-coding transcript of Ifng-as1. Mol. Cell 75, 1229\u20131242 e1225 (2019).","journal-title":"Mol. Cell"},{"key":"1535_CR185","doi-asserted-by":"publisher","first-page":"8307280","DOI":"10.1155\/2022\/8307280","volume":"2022","author":"H He","year":"2022","unstructured":"He, H. et al. lncRNA STAT4-AS1 inhibited TH17 cell differentiation by targeting ROR\u03b3t protein. J. Immunol. Res. 2022, 8307280 (2022).","journal-title":"J. Immunol. Res."},{"key":"1535_CR186","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13578-019-0346-3","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p\/IER3 pathway. Cell Biosci. 9, 84 (2019).","journal-title":"Cell Biosci."},{"key":"1535_CR187","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259\u2013283 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"1535_CR188","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2017.00311","volume":"8","author":"KJ Binger","year":"2017","unstructured":"Binger, K. J., Corte-Real, B. F. & Kleinewietfeld, M. Immunometabolic regulation of interleukin-17-producing T helper cells: uncoupling new targets for autoimmunity. Front. Immunol. 8, 311 (2017).","journal-title":"Front. Immunol."},{"key":"1535_CR189","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194\u2013207 (2015).","journal-title":"J. Clin. Invest."},{"key":"1535_CR190","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/febs.15853","volume":"289","author":"G Papadopoulou","year":"2022","unstructured":"Papadopoulou, G. & Xanthou, G. Metabolic rewiring: a new master of Th17 cell plasticity and heterogeneity. FEBS J. 289, 2448\u20132466 (2022).","journal-title":"FEBS J."},{"key":"1535_CR191","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327\u20131333 (2014).","journal-title":"Nat. Med."},{"key":"1535_CR192","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"1535_CR193","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fimmu.2019.00115","volume":"10","author":"D Cluxton","year":"2019","unstructured":"Cluxton, D., Petrasca, A., Moran, B. & Fletcher, J. M. Differential regulation of human Treg and Th17 cells by fatty acid synthesis and glycolysis. Front. Immunol. 10, 115 (2019).","journal-title":"Front. Immunol."},{"key":"1535_CR194","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4049\/jimmunol.1301158","volume":"192","author":"DC Saucillo","year":"2014","unstructured":"Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C. & Maciver, N. J. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J. Immunol. 192, 136\u2013144 (2014).","journal-title":"J. Immunol."},{"key":"1535_CR195","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/eji.201545861","volume":"46","author":"VA Gerriets","year":"2016","unstructured":"Gerriets, V. A. et al. Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity. Eur. J. Immunol. 46, 1970\u20131983 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1535_CR196","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.4049\/jimmunol.1402996","volume":"194","author":"BS Reis","year":"2015","unstructured":"Reis, B. S. et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J. Immunol. 194, 5253\u20135260 (2015).","journal-title":"J. Immunol."},{"key":"1535_CR197","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"181","author":"S Xiao","year":"2008","unstructured":"Xiao, S. et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-\u03b2-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277\u20132284 (2008).","journal-title":"J. Immunol."},{"key":"1535_CR198","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","volume":"111","author":"KM Elias","year":"2008","unstructured":"Elias, K. M. et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/Stat-5 independent signaling pathway. Blood 111, 1013\u20131020 (2008).","journal-title":"Blood"},{"key":"1535_CR199","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"D Mucida","year":"2007","unstructured":"Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256\u2013260 (2007).","journal-title":"Science"},{"key":"1535_CR200","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0145-2126(93)90100-Y","volume":"17","author":"M Sakakibara","year":"1993","unstructured":"Sakakibara, M. et al. Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leuk. Res. 17, 441\u2013443 (1993).","journal-title":"Leuk. Res."},{"key":"1535_CR201","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","volume":"548","author":"T Xu","year":"2017","unstructured":"Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228\u2013233 (2017).","journal-title":"Nature"},{"key":"1535_CR202","doi-asserted-by":"publisher","first-page":"793428","DOI":"10.3389\/fcell.2021.793428","volume":"9","author":"M Huo","year":"2021","unstructured":"Huo, M., Zhang, J., Huang, W. & Wang, Y. Interplay among metabolism, epigenetic modifications, and gene expression in cancer. Front. Cell Dev. Biol. 9, 793428 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1535_CR203","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","volume":"175","author":"MO Johnson","year":"2018","unstructured":"Johnson, M. O. et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell 175, 1780\u20131795 (2018).","journal-title":"Cell"},{"key":"1535_CR204","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","volume":"31","author":"DG Roy","year":"2020","unstructured":"Roy, D. G. et al. Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming. Cell Metab. 31, 250\u2013266 (2020).","journal-title":"Cell Metab."},{"key":"1535_CR205","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","volume":"108","author":"YK Lee","year":"2011","unstructured":"Lee, Y. K., Menezes, J. S., Umesaki, Y. & Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108, 4615\u20134622 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR206","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu, H. J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815\u2013827 (2010).","journal-title":"Immunity"},{"key":"1535_CR207","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.chom.2017.10.007","volume":"22","author":"CP Bradley","year":"2017","unstructured":"Bradley, C. P. et al. Segmented filamentous bacteria provoke lung autoimmunity by inducing gut\u2013lung axis Th17 cells expressing dual TCRs. Cell Host Microbe 22, 697\u2013704 e694 (2017).","journal-title":"Cell Host Microbe"},{"key":"1535_CR208","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-2634-9","volume":"585","author":"E Miyauchi","year":"2020","unstructured":"Miyauchi, E. et al. Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature 585, 102\u2013106 (2020).","journal-title":"Nature"},{"key":"1535_CR209","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538\u2013541 (2011).","journal-title":"Nature"},{"key":"1535_CR210","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","volume":"183","author":"J Ochoa-Reparaz","year":"2009","unstructured":"Ochoa-Reparaz, J. et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183, 6041\u20136050 (2009).","journal-title":"J. Immunol."},{"key":"1535_CR211","doi-asserted-by":"publisher","unstructured":"Mindur, J. E. et al. Surface layer protein A expressed in Clostridioides difficile DJNS06-36 possesses an encephalitogenic mimotope of myelin basic protein. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9010034 (2020).","DOI":"10.3390\/microorganisms9010034"},{"key":"1535_CR212","doi-asserted-by":"publisher","first-page":"e1700492","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich, I. et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci. Adv. 3, e1700492 (2017).","journal-title":"Sci. Adv."},{"key":"1535_CR213","doi-asserted-by":"publisher","first-page":"e0137429","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake, S. et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One 10, e0137429 (2015).","journal-title":"PLoS One"},{"key":"1535_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi, S. et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 7, 12015 (2016).","journal-title":"Nat. Commun."},{"key":"1535_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 6, 28484 (2016).","journal-title":"Sci. Rep."},{"key":"1535_CR216","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","volume":"40","author":"Y Goto","year":"2014","unstructured":"Goto, Y. et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40, 594\u2013607 (2014).","journal-title":"Immunity"},{"key":"1535_CR217","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nature13279","volume":"510","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510, 152\u2013156 (2014).","journal-title":"Nature"},{"key":"1535_CR218","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367\u2013380 (2015).","journal-title":"Cell"},{"key":"1535_CR219","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.cell.2020.12.008","volume":"183","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell 183, 2036\u20132039 (2020).","journal-title":"Cell"},{"key":"1535_CR220","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"1535_CR221","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","volume":"603","author":"D Paik","year":"2022","unstructured":"Paik, D. et al. Human gut bacteria produce TH17-modulating bile acid metabolites. Nature 603, 907\u2013912 (2022).","journal-title":"Nature"},{"key":"1535_CR222","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"1535_CR223","doi-asserted-by":"publisher","first-page":"152126","DOI":"10.1016\/j.imbio.2021.152126","volume":"226","author":"JJ Kibbie","year":"2021","unstructured":"Kibbie, J. J. et al. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling. Immunobiology 226, 152126 (2021).","journal-title":"Immunobiology"},{"key":"1535_CR224","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR\u2013S6K pathway. Mucosal Immunol. 8, 80\u201393 (2015).","journal-title":"Mucosal Immunol."},{"key":"1535_CR225","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcp.2006.01.007","volume":"72","author":"PA Harper","year":"2006","unstructured":"Harper, P. A., Riddick, D. S. & Okey, A. B. Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem. Pharm. 72, 267\u2013279 (2006).","journal-title":"Biochem. Pharm."},{"key":"1535_CR226","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41385-018-0019-2","volume":"11","author":"B Lamas","year":"2018","unstructured":"Lamas, B., Natividad, J. M. & Sokol, H. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 11, 1024\u20131038 (2018).","journal-title":"Mucosal Immunol."},{"key":"1535_CR227","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06881","volume":"453","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106\u2013109 (2008).","journal-title":"Nature"},{"key":"1535_CR228","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana, F. J. et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65\u201371 (2008).","journal-title":"Nature"},{"key":"1535_CR229","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1084\/jem.20081438","volume":"206","author":"M Veldhoen","year":"2009","unstructured":"Veldhoen, M., Hirota, K., Christensen, J., O\u2019Garra, A. & Stockinger, B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206, 43\u201349 (2009).","journal-title":"J. Exp. Med."},{"key":"1535_CR230","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.immuni.2020.01.006","volume":"52","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Febrile temperature critically controls the differentiation and pathogenicity of T helper 17 cells. Immunity 52, 328\u2013341 (2020).","journal-title":"Immunity"},{"key":"1535_CR231","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","volume":"496","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518\u2013522 (2013).","journal-title":"Nature"},{"key":"1535_CR232","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513\u2013517 (2013).","journal-title":"Nature"},{"key":"1535_CR233","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fimmu.2017.01969","volume":"8","author":"SLF Aguiar","year":"2017","unstructured":"Aguiar, S. L. F. et al. High-salt diet induces IL-17-dependent gut inflammation and exacerbates colitis in mice. Front. Immunol. 8, 1969 (2017).","journal-title":"Front. Immunol."},{"key":"1535_CR234","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.it.2012.08.007","volume":"33","author":"A Arjona","year":"2012","unstructured":"Arjona, A., Silver, A. C., Walker, W. E. & Fikrig, E. Immunity\u2019s fourth dimension: approaching the circadian-immune connection. Trends Immunol. 33, 607\u2013612 (2012).","journal-title":"Trends Immunol."},{"key":"1535_CR235","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1101\/gad.228536.113","volume":"28","author":"JS Menet","year":"2014","unstructured":"Menet, J. S., Pescatore, S. & Rosbash, M. CLOCK:BMAL1 is a pioneer-like transcription factor. Genes Dev. 28, 8\u201313 (2014).","journal-title":"Genes Dev."},{"key":"1535_CR236","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1243884","volume":"342","author":"X Yu","year":"2013","unstructured":"Yu, X. et al. TH17 cell differentiation is regulated by the circadian clock. Science 342, 727\u2013730 (2013).","journal-title":"Science"},{"key":"1535_CR237","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8000","volume":"6","author":"XC Dopico","year":"2015","unstructured":"Dopico, X. C. et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 6, 7000 (2015).","journal-title":"Nat. Commun."},{"key":"1535_CR238","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJM199701163360306","volume":"336","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski, A. Melatonin in humans. N. Engl. J. Med. 336, 186\u2013195 (1997).","journal-title":"N. Engl. J. Med."},{"key":"1535_CR239","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0022-510X(00)00408-1","volume":"181","author":"Y Jin","year":"2000","unstructured":"Jin, Y., de Pedro-Cuesta, J., Soderstrom, M., Stawiarz, L. & Link, H. Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J. Neurol. Sci. 181, 56\u201364 (2000).","journal-title":"J. Neurol. Sci."},{"key":"1535_CR240","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ana.24287","volume":"76","author":"T Spelman","year":"2014","unstructured":"Spelman, T. et al. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Ann. Neurol. 76, 880\u2013890 (2014).","journal-title":"Ann. Neurol."},{"key":"1535_CR241","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cell.2015.08.025","volume":"162","author":"MF Farez","year":"2015","unstructured":"Farez, M. F. et al. Melatonin contributes to the seasonality of multiple sclerosis relapses. Cell 162, 1338\u20131352 (2015).","journal-title":"Cell"},{"key":"1535_CR242","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka, Y., Luo, Y., O\u2019Shea, J. J. & Nakayamada, S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat. Rev. Rheumatol. 18, 133\u2013145 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1535_CR243","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","volume":"13","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Small molecule inhibitors of ROR\u03b3t for Th17 regulation in inflammatory and autoimmune diseases. J. Pharm. Anal. 13, 545\u2013562 (2023).","journal-title":"J. Pharm. Anal."},{"key":"1535_CR244","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.celrep.2016.11.073","volume":"17","author":"Y Guo","year":"2016","unstructured":"Guo, Y. et al. Inhibition of ROR\u03b3T skews TCR\u03b1 gene rearrangement and limits T cell repertoire diversity. Cell Rep. 17, 3206\u20133218 (2016).","journal-title":"Cell Rep."},{"key":"1535_CR245","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11255-4","volume":"7","author":"M Yasunaga","year":"2017","unstructured":"Yasunaga, M., Manabe, S. & Matsumura, Y. Immunoregulation by IL-7R-targeting antibody\u2013drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease. Sci. Rep. 7, 10735 (2017).","journal-title":"Sci. Rep."},{"key":"1535_CR246","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803\u20132812 (2007).","journal-title":"J. Exp. Med."},{"key":"1535_CR247","doi-asserted-by":"publisher","first-page":"e12846","DOI":"10.1111\/sji.12846","volume":"91","author":"K Furue","year":"2020","unstructured":"Furue, K., Ito, T., Tsuji, G., Nakahara, T. & Furue, M. The CCL20 and CCR6 axis in psoriasis. Scand. J. Immunol. 91, e12846 (2020).","journal-title":"Scand. J. Immunol."},{"key":"1535_CR248","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu, L., Li, R., Huang, Y. & Wang, S. The IL-17 family in diseases: from bench to bedside. Signal Transduct. Target. Ther. 8, 402 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1535_CR249","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2023.06.012","volume":"56","author":"Q Luo","year":"2023","unstructured":"Luo, Q. et al. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression. Immunity 56, 2006\u20132020 (2023).","journal-title":"Immunity"},{"key":"1535_CR250","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1056\/NEJMoa2308713","volume":"390","author":"R Bissonnette","year":"2024","unstructured":"Bissonnette, R. et al. An oral interleukin-23-receptor antagonist peptide for plaque psoriasis. N. Engl. J. Med. 390, 510\u2013521 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1535_CR251","doi-asserted-by":"publisher","unstructured":"Berger, S. et al. Preclinical proof of principle for orally delivered Th17 antagonist miniproteins. Cell https:\/\/doi.org\/10.1016\/j.cell.2024.05.052 (2024).","DOI":"10.1016\/j.cell.2024.05.052"},{"key":"1535_CR252","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jaci.2023.05.012","volume":"152","author":"J Kim","year":"2023","unstructured":"Kim, J. et al. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis. J. Allergy Clin. Immunol. 152, 656\u2013666 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1535_CR253","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jbspin.2013.03.014","volume":"80","author":"A Grasland","year":"2013","unstructured":"Grasland, A., Mahe, E., Raynaud, E. & Mahe, I. Psoriasis onset with tocilizumab. Joint Bone Spine 80, 541\u2013542 (2013).","journal-title":"Joint Bone Spine"},{"key":"1535_CR254","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3899\/jrheum.111166","volume":"39","author":"D Wendling","year":"2012","unstructured":"Wendling, D., Letho-Gyselinck, H., Guillot, X. & Prati, C. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J. Rheumatol. 39, 657 (2012).","journal-title":"J. Rheumatol."},{"key":"1535_CR255","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jid.2016.11.022","volume":"137","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt, A. IL-6 differs from TNF-\u03b1: unpredicted clinical effects caused by IL-6 blockade in psoriasis. J. Invest. Dermatol. 137, 541\u2013542 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR256","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jid.2016.10.021","volume":"137","author":"Y Fritz","year":"2017","unstructured":"Fritz, Y. et al. Induction of alternative proinflammatory cytokines accounts for sustained psoriasiform skin inflammation in IL-17C+IL-6KO mice. J. Invest. Dermatol. 137, 696\u2013705 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"1535_CR257","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1517\/13543784.2012.712112","volume":"21","author":"SA Antoniu","year":"2012","unstructured":"Antoniu, S. A. Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis. Expert Opin. Invest. Drugs 21, 1607\u20131618 (2012).","journal-title":"Expert Opin. Invest. Drugs"},{"key":"1535_CR258","first-page":"275","volume":"2","author":"D Guagnozzi","year":"2008","unstructured":"Guagnozzi, D. & Caprilli, R. Natalizumab in the treatment of Crohn\u2019s disease. Biologics 2, 275\u2013284 (2008).","journal-title":"Biologics"},{"key":"1535_CR259","first-page":"265","volume":"18","author":"T Choden","year":"2022","unstructured":"Choden, T., Cohen, N. A. & Rubin, D. T. Sphingosine-1 phosphate receptor modulators: the next wave of oral therapies in inflammatory bowel disease. Gastroenterol. Hepatol. 18, 265\u2013271 (2022).","journal-title":"Gastroenterol. Hepatol."},{"key":"1535_CR260","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1084\/jem.20110434","volume":"208","author":"V Rothhammer","year":"2011","unstructured":"Rothhammer, V. et al. Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J. Exp. Med. 208, 2465\u20132476 (2011).","journal-title":"J. Exp. Med."},{"key":"1535_CR261","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20140540","volume":"211","author":"T Schneider-Hohendorf","year":"2014","unstructured":"Schneider-Hohendorf, T. et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J. Exp. Med. 211, 1833\u20131846 (2014).","journal-title":"J. Exp. Med."},{"key":"1535_CR262","doi-asserted-by":"publisher","first-page":"e2209944120","DOI":"10.1073\/pnas.2209944120","volume":"120","author":"C Janoschka","year":"2023","unstructured":"Janoschka, C. et al. Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound. Proc. Natl Acad. Sci. USA 120, e2209944120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1535_CR263","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F Muller","year":"2024","unstructured":"Muller, F. et al. CD19 CAR T-cell therapy in autoimmune disease\u2014a case series with follow-up. N. Engl. J. Med. 390, 687\u2013700 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1535_CR264","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1474-4422(23)00194-1","volume":"22","author":"V Granit","year":"2023","unstructured":"Granit, V. et al. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b\/2a study. Lancet Neurol. 22, 578\u2013590 (2023).","journal-title":"Lancet Neurol."},{"key":"1535_CR265","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41587-022-01637-z","volume":"41","author":"S Oh","year":"2023","unstructured":"Oh, S. et al. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. Nat. Biotechnol. 41, 1229\u20131238 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1535_CR266","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nbt758","volume":"20","author":"MD Jyothi","year":"2002","unstructured":"Jyothi, M. D., Flavell, R. A. & Geiger, T. L. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes. Nat. Biotechnol. 20, 1215\u20131220 (2002).","journal-title":"Nat. Biotechnol."},{"key":"1535_CR267","doi-asserted-by":"publisher","unstructured":"Cui, Y. et al. IL23R-specific CAR Tregs for the treatment of Crohn\u2019s disease. J. Crohns Colitis https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae135 (2024).","DOI":"10.1093\/ecco-jcc\/jjae135"},{"key":"1535_CR268","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.immuni.2020.01.002","volume":"52","author":"AM McGinley","year":"2020","unstructured":"McGinley, A. M. et al. Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1\u03b2-producing myeloid cells that promote pathogenic T cells. Immunity 52, 342\u2013356 (2020).","journal-title":"Immunity"},{"key":"1535_CR269","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.4049\/jimmunol.161.12.6480","volume":"161","author":"EB Samoilova","year":"1998","unstructured":"Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480\u20136486 (1998).","journal-title":"J. Immunol."},{"key":"1535_CR270","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/intimm\/10.5.703","volume":"10","author":"Y Okuda","year":"1998","unstructured":"Okuda, Y. et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703\u2013708 (1998).","journal-title":"Int. Immunol."},{"key":"1535_CR271","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D","volume":"28","author":"HP Eugster","year":"1998","unstructured":"Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. & Fontana, A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178\u20132187 (1998).","journal-title":"Eur. J. Immunol."},{"key":"1535_CR272","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li, M. O., Wan, Y. Y. & Flavell, R. A. T cell-produced transforming growth factor-\u03b21 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579\u2013591 (2007).","journal-title":"Immunity"},{"key":"1535_CR273","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/ibd.21476","volume":"17","author":"J Mudter","year":"2011","unstructured":"Mudter, J. et al. IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo. Inflamm. Bowel Dis. 17, 1343\u20131358 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"1535_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17597-3","volume":"7","author":"S Yamazaki","year":"2017","unstructured":"Yamazaki, S. et al. The AP-1 transcription factor JunB is required for Th17 cell differentiation. Sci. Rep. 7, 17402 (2017).","journal-title":"Sci. Rep."},{"key":"1535_CR275","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","volume":"179","author":"TJ Harris","year":"2007","unstructured":"Harris, T. J. et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179, 4313\u20134317 (2007).","journal-title":"J. Immunol."},{"key":"1535_CR276","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/art.40447","volume":"70","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. Augmented Th17 differentiation leads to cutaneous and synovio-entheseal inflammation in a novel model of psoriatic arthritis. Arthritis Rheumatol. 70, 855\u2013867 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1535_CR277","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1301360","volume":"191","author":"LK Fogli","year":"2013","unstructured":"Fogli, L. K. et al. T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. J. Immunol. 191, 3100\u20133111 (2013).","journal-title":"J. Immunol."},{"key":"1535_CR278","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ni1391","volume":"7","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen, M., Hocking, R. J., Flavell, R. A. & Stockinger, B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151\u20131156 (2006).","journal-title":"Nat. Immunol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01535-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:43:19Z","timestamp":1759981399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01535-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":278,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1535"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01535-9","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}